Kidney Cancer Journal | Volume 4, Issue 3
The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice...
Read More
Topic: Advanced Disease
Kidney Cancer Journal | Volume 4, Issue 2
Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma Abstract With the...
Read More
Kidney Cancer Journal | Volume 4, Issue 1
The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review...
Read More
Kidney Cancer Journal | Volume 3, Issue 4
Immune Checkpoint Inhibition, the Key to Success in Renal Cell Carcinoma?Treatment of renal cell...
Read More
Renal Autotransplant, When All Else Fails
Michael S. Davis, MD, provides a brief history of transplant surgery, discusses the indications for renal autotransplant, and reviews proper surgical techniques for this procedure. He also stresses the importance of coordinating with the transplant and vascular surgery team for success in these cases.
Read More
Kidney Cancer Journal | Volume 3, Issue 3
Genomic Instability in Kidney Cancer: Etiologies and Treatment Opportunities Genomic instability...
Read More
Kidney Cancer Journal | Volume 3, Issue 2
The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the...
Read More
Recent Advances for Renal Cell Carcinoma: A 2018 Review
Erik P. Castle, MD, highlights recent advances in surgery, individualized medicines, and immunotherapies for patients with renal cell carcinoma (RCC). He reviews updates in genetic sequencing and CAR-T cell therapy, as well as developing role of cancer-associated macrophage-like cells (CAMLs), in these patients.
Read More
Adjuvant Therapy in High Risk Renal Cell Carcinoma
Alan H. Bryce, MD, surveys data from three phase III trials on adjuvant therapies for high-risk renal cell carcinoma. He discusses the controversies following the conclusions of the completed trials and emphasizes the need for research in further adjuvant therapies beyond those that target the VEGF pathway.
Read More
Kidney Cancer Journal | Volume 3, Issue 1
Radiation Therapy for Renal Cell Carcinoma Radiation therapy (RT) has traditionally been...
Read More
The Bottom Line: Practical Application of Clinical Trial Data to Advanced Renal Cell Carcinoma
Wesley A. Mayer, MD, reviews the landmark trials that set the standard of care for cytoreductive nephrectomy (CN) and the impact of targeted therapy on this technique. He discusses recent clinical trials on CN and targeted therapy, as well as data regarding cytoreductive partial nephrectomy.
Read More
Controversies in Renal Cell Carcinoma: Adjuvant TKIs and Clinical Trial Updates
Daniel P. Petrylak, MD, provides a brief update on the controversial use of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma. He also reviews a study assessing sunitinib versus sunitinib plus nephrectomy in metastatic renal cell carcinoma.
Read More
Exercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan